Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
| Actual shortage: | 243 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-09-09 | 2020-12-07 | 123951 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2020-09-17 | 2020-09-25 | 124347 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-18 | 2021-01-19 | 130410 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-08 | 2021-01-12 | 131154 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2021-02-26 | 2021-03-24 | 134820 |
| APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-02-26 | 2021-03-19 | 134823 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2021-03-26 | 2021-04-12 | 136406 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2021-04-23 | 2021-06-28 | 137962 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-05-07 | 2021-06-14 | 138966 |
| APO-CEFUROXIME | 250MG | TABLET | Resolved | 2021-09-17 | 2021-10-12 | 145828 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-10-01 | 2021-10-01 | 146511 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2022-01-07 | 2022-03-21 | 152298 |
| APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-01-07 | 2022-02-04 | 152307 |
| APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-02-25 | 2022-03-24 | 155603 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-04-08 | 2022-06-12 | 158373 |
| APO-GEFITINIB | 250MG | TABLET | Resolved | 2022-04-14 | 2022-06-24 | 158819 |
| APO-DIVALPROEX | 250MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-04-29 | 2022-07-28 | 159700 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-06-17 | 2024-02-14 | 162918 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2022-07-15 | 2022-09-23 | 164701 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164710 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
| APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
| APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |